Company news
Crescita Therapeutics, Inc. (TSX:CTX) news
Crescita Therapeutics, Inc. news releases on 6ix. Latest, Dec 17, 2018: U.S. FDA Approves Removal of "Not for Home Use" Label Restriction for Pliaglis®
Press releases — page 2
U.S. FDA Approves Removal of "Not for Home Use" Label Restriction for Pliaglis®
December 17, 2018
Crescita Therapeutics(TM) Reports 2018 Third Quarter Results Strong Royalty Revenue and Achievement of First Pliaglis US Sales Milestone Positive Adjusted EBITDA of $0.8M
November 9, 2018
Crescita Reinvigorates Skincare Line Leveraging its MMPE(TM) Technology and Becomes One of the First Companies Worldwide to Release Anti-Ageing Formulation Using ECOBIOTYS®
November 8, 2018
Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol
October 15, 2018
Crescita Therapeutics(TM) Reports 2018 Second Quarter Results
August 10, 2018
Crescita Therapeutics Inc. to Present at The MicroCap Conference on June 21st in Toronto
June 19, 2018
Crescita Therapeutics(TM) Announces Director Election Results of its Annual General Meeting
June 13, 2018
Crescita Therapeutics(TM) Reports 2018 First Quarter Results
May 9, 2018
Crescita Therapeutics(TM) To Present at the 2018 Bloom Burton &Co. Healthcare Investor Conference in Toronto
April 26, 2018
Crescita Therapeutics Inc. Adds Recognized Skincare Expert to its Leadership Team
April 5, 2018
Crescita Therapeutics(TM) Announces the Appointment of Serge Verreault as President & CEO
April 3, 2018
Crescita Announces Launch of Pliaglis in U.S.
March 29, 2018
Crescita Therapeutics(TM) Reports 2017 Fourth Quarter and Year End Results
March 28, 2018
Crescita Therapeutics Inc. Announces Completion of Oversubscribed Rights Offering
March 12, 2018
Crescita Therapeutics Inc. Announces Rights Offering to Raise Up To $3.7 Million
January 31, 2018
Crescita Therapeutics(TM) Announces 2017 Third Quarter Results and Appoints New CFO
November 10, 2017
Crescita Therapeutics(TM) Reports Positive Topline Results of Phase 2 Clinical Trial for the Treatment of Plaque Psoriasis
September 18, 2017
Crescita Therapeutics(TM) Announces Completion of $1.0 million Convertible Debenture Financing with Bloom Burton Funds
August 29, 2017
Crescita Therapeutics(TM) Announces Amended Loan Agreement with Knight Therapeutics
August 14, 2017
Crescita Therapeutics(TM) Announces Profitable 2017 Second Quarter Results
August 13, 2017
Crescita Therapeutics(TM) Announces Acquisition of Alyria® Skincare Products
August 8, 2017
Daily Coverage on Healthcare Stocks: BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
July 12, 2017
Research Reports Initiated on Healthcare Stocks BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics
June 2, 2017
Crescita Therapeutics(TM) Announces 2017 First Quarter Results
May 14, 2017
Crescita Therapeutics(TM) Announces Agreement with Taro Pharmaceuticals for Pliaglis®
April 25, 2017
Crescita Therapeutics(TM) Announces the Appointment of a New President
April 12, 2017
Crescita Therapeutics(TM) Announces 2016 Fourth Quarter and Year-End Results
March 30, 2017
Crescita Therapeutics(TM) Announces Signing of a Licensing Agreement Utilizing its MMPE(TM) Technology
March 21, 2017
Crescita Therapeutics(TM) Announces Management and Board Changes
February 10, 2017
Crescita Therapeutics(TM) Announces Launch of ISDIN® Product Line at Brunet Pharmacy
January 26, 2017
Crescita Therapeutics(TM) Announces 2016 Third Quarter Results
November 14, 2016
Crescita Appoints Dan Chicoine as Interim CEO
November 3, 2016
Crescita Therapeutics(TM) Announces Changes to the Board of Directors
September 29, 2016
Crescita Therapeutics(TM) Announces Approval of Pliaglis in Mexico
September 9, 2016
IIROC Trade Resumption - Crescita Therapeutics Inc.
September 1, 2016
IIROC Trade Resumption - CTX
September 1, 2016
IIROC Trading Halt - CTX
September 1, 2016
Crescita Therapeutics(TM) Inc. Announces Acquisition of INTEGA Skin Sciences
September 1, 2016
Crescita Therapeutics(TM) Announces 2016 Second Quarter Results
July 27, 2016
Crescita Therapeutics(TM) Provides an Update on its Immunology Group Wind-Down
July 12, 2016
Crescita Therapeutics(TM) Announces 2016 First Quarter Results
May 10, 2016
Crescita Therapeutics Inc. Opens the Market
April 26, 2016
Crescita Therapeutics(TM) Inc. Provides Corporate Update
March 7, 2016
Nuvo Research® Inc. Completes Reorganization into Two Publicly Traded Companies
March 1, 2016